Covered recipient · General Payments record
BENJAMIN LEACH
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$14,301.70
- Reported across 135 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $4,895.00 | 2 |
| Food and Beverage | $538.66 | 6 |
| Travel and Lodging | $17.37 | 1 |
| Education | $16.40 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $2,921.13 | 4 |
| Acerta Pharma LLC | $2,220.00 | 1 |
| Kite Pharma, Inc. | $150.00 | 1 |
| ImmunoGen, Inc. | $86.51 | 1 |
| INTUITIVE SURGICAL, INC. | $56.39 | 1 |
| Celgene Corporation | $17.00 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,220.00 | 06/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105481469 | CMS |
| Celgene Corporation | $17.00 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101079371 | CMS |
| GENZYME CORPORATION | $103.76 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139876539 | CMS |
| GENZYME CORPORATION | $125.00 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139876617 | CMS |
| GENZYME CORPORATION | $2,675.00 | 08/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139876619 | CMS |
| GENZYME CORPORATION | $17.37 | 08/20/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139876621 | CMS |
| ImmunoGen, Inc. | $86.51 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099941663 | CMS |
| INTUITIVE SURGICAL, INC. | $56.39 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137213749 | CMS |
| Kite Pharma, Inc. | $150.00 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128614297 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.40 | 02/16/2024 | Education | Undisputed | 01/23/2026 | 1144961514 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.